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Abstract
Memory consolidation, which converts acquired information into long-term storage, is new protein synthesis-dependent. As
protein synthesis is a dynamic process that is under the control of multiple translational mechanisms, however, it is still
elusive how these mechanisms are recruited in response to learning for memory consolidation. Here we found that
eukaryotic elongation factor-2 (eEF-2) was dramatically dephosphorylated within 0.5–2 hr in the hippocampus and
amygdala of mice following training in a fear-conditioning test, whereas genome-wide microarrays did not reveal any
significant change in the expression level of the mRNAs for translational machineries or their related molecules. Moreover,
blockade of NMDA receptors with MK-801 immediately following the training significantly impeded both the post-training
eEF-2 dephosphorylation and memory retention. Notably, with an elegant sophisticated transgenic strategy, we
demonstrated that hippocampus-specific overexpression of eEF-2 kinase, a kinase that specifically phosphorylates and
hence inactivates eEF-2, significantly inhibited protein synthesis in the hippocampus, and this effects was more robust
during an ‘‘ongoing’’ protein synthesis process. As a result, late phase long-term potentiation (L-LTP) in the hippocampus
and long-term hippocampus-dependent memory in the mice were significantly impaired, whereas short-term memory and
long-term hippocampus-independent memory remained intact. These results reveal a novel translational underpinning for
protein synthesis pertinent to memory consolidation in the mammalian brain.
Citation: Im H-I, Nakajima A, Gong B, Xiong X, Mamiya T, et al. (2009) Post-Training Dephosphorylation of eEF-2 Promotes Protein Synthesis for Memory
Consolidation. PLoS ONE 4(10): e7424. doi:10.1371/journal.pone.0007424
Editor: Hiromu Tanimoto, Max-Planck-Institut fuer Neurobiologie, Germany
Received March 19, 2009; Accepted September 19, 2009; Published October 13, 2009
Copyright:  2009 Im et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: HII was partially supported by the Geraldi Norton foundation and Christopher Eklund Family foundation. TM was partially supported from the Graduate
School of Pharmaceutical Science, Major University, Nagoya, Japan. This study was supported by grants from NIMH/NIH (MH066243), Alzheimer’s Association
(NIRG-02-4368), and NSF (0213112), all to YPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ytang1@lsuhsc.edu
¤a Current address: Department of Molecular Therapeutics, Scripps Florida, Jupiter, Florida, United States of America
¤b Current address: Laboratory of Pharmacotherapy, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
. These authors contributed equally to this work.
Introduction
The process of learning and memory may be divided into
several sequential steps, including acquisition, consolidation,
storage, and retrieval [1,2]. As the initial step, acquisition requires
the brain to be at a higher arousal level in order to acquire new
information as much as possible. However, only a very small
portion of the acquired information may be further processed in
the brain for long-term storage, a process that is called memory
consolidation [3]. Consolidated memory traces are then trans-
ferred to certain brain regions such as the cortex for long-term
storage. As consolidated information is retrievable over hours,
days, months, and even up to the whole lifetime, this type of
memory, called long-term memory, plays an essential role in
human intelligent life. In contrast, information that does not
undergo a consolidating process can only last for seconds or
minutes. This type of memory is called short-term memory [4,5].
Without any doubt, to explore the molecular and neuronal
mechanisms underlying memory consolidation is not only
fundamental for our understanding of how acquired information
is encoded in the brain but also insightful for disclosing how long-
term memory formation could be impaired even though the
acquisition is normal. This is of particular interest, as this kind of
mnemonic dysfunction is often observed in many pathological
conditions and clinical entities such as abnormal aging, mental
retardation, and an early stage of neurodegenerative disease such
as Alzheimer’s disease [6–8].
A milestone over the past century for the studies of learning and
memory is the demonstration that de novo new protein synthesis is
required for memory consolidation [9,10],although recent evidence
indicates that post-translational modifications of certain existing
proteins may also be important for early consolidation [11]. This
milestone has been established based essentially on the studies with
the use of pharmacological/neurosurgical approaches. For exam-
ple, post-training infusion of a protein synthesis inhibitor such as
anisomycin into the hippocampus, amygdala, and motor cortex of
the animals significantly impairs hippocampal, emotional, and
motor memory, respectively [12–15]. An important advantage of
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specificity (within a special time window during the process of
learning and memory) and spatial-specificity (targeting on a
particular brain region), both of which allow a real-time/on-site
coupling analysis of learning behavior in free-moving animals.
However, as protein synthesis itself is a series of complicated
biochemical reactions, it is still unclear how a neuronal process
(learning) bridges to these biochemical reactions in the brain.
In mammalian cells, protein synthesis is mediated by interac-
tions between a target mRNA and translational machineries
including ribosomal proteins, eukaryote initiation factors (eIFs),
and eukaryote elongation factors (eEFs). Upon mRNAs available,
eIFs such as eIF4E recognize and bind to a target mRNA, and
then eEFs such as eEF-2 mediate the polypeptide elongation
[16,17]. Importantly, the activities of these translational machin-
eries are regulated by many other molecules such as eEF-2 kinase
(eEF-2K), eIF-binding proteins, etc. [16,17], all of which are called
‘‘translational machinery-related molecules’’ here. An important
regulatory mechanism for most of these molecules is phosphory-
lation/dephosphorylation. Hyperphosphorylation of eIF4E-bind-
ing protein-1 by mammalian target of rapamycin (mTOR), for
example, activates eIF4E, and consequently, promotes protein
synthesis [18,19]. Phosphorylation of eEF-2 by eEF-2K inactivates
eEF-2 and therefore, significantly inhibits protein synthesis [20],
although the effect of eEF-2K might depend on certain condition
in an in vitro system [21]. Originally known as Ca
2+-calmodulin-
dependent protein kinase III [22], eEF-2K is present in all cells in
the body [23]. It is therefore reasonably to speculate that an
alteration in either the expression level or the phosphorylation
state of these translational machineries or their related molecules
including eEF-2K may significantly change the process of protein
synthesis, which in turn may facilitate or impede a particular long-
lasting biological process such as memory consolidation.
In this report, we provide compelling evidence at the molecular,
pharmacological, genetic, and behavioral levels that post-training
dephosphorylation of eEF-2 is a key translational mechanism for
protein synthesis pertinent to memory consolidation in the brain.
Results
Post-training expression of mRNAs for translational
machineries and their related molecules in brains of mice
following training in a fear-conditioning test (FCT)
The FCT is the most commonly used behavioral paradigm for
the studies of long-lasting fear memory in the rodent [24]. In order
to determine whether training in the FCT altered the expression of
translational machineries or/and their related molecules in the
brain regions that are critically involved in consolidating fear
memory, genome-wide cDNA microarrays were used to screen
gene expression profiles in the hippocampus, amygdala, and
cortex. A time-course of 30, 60, and 120 min after the training,
together with a control group, was examined. As shown in Figure 1
and Table 1, some neuronal activity-related genes such as c-fos,
BDNF, and Arc were up-regulated in the hippocampus of mice
after the training, whereas the expression of mRNAs for ribosome,
eIFs, eIF-binding proteins, eEFs, eIF kinase, eEF-2K, mTOR,
p70S6 kinase, and p90 RSK1 kinase, etc. was not significantly
changed, in comparison with those in control mice. Similar results
were observed in the amygdala and cortex (data not shown),
indicating that changes in the expression level of the mRNAs for
the translational machineries and their related molecules are
unlikely to be a mechanism that is pivotal for memory
consolidation-associated protein synthesis.
Dephosphorylation of eEF-2 (dephospho-eEF-2) in both
the hippocampus and amygdala was temporarily
associated with post-training
We next focused on whether the phosphorylation of eEF-2
(phospho-eEF-2) in brains of mice altered after the training in FCT.
A time-course of 30 min, 2 hr, and 4 hr was examined. In order to
exclude any non-specific effect, four control conditions, naı ¨ve control
(NC), shock control (SC), contextual control (CC), and tone control
(TC), were examined. At 30 min, the level of phospho-eEF-2 in the
hippocampus (Figure 2A), amygdala (Figure 2D), but not the cortex
(data not shown), was dramatically decreased, compared to that in the
same brain regions of control mice. After normalization to the NC
level, about 25–35%, 24–38%, and 3–7% of eEF-2 was dephosphor-
ylated in the hippocampus (Figure 2B), amygdala (Figure 2E), and
cortex (data not shown), respectively, and an ANOVA revealed a
significant difference in dephospho-eEF-2 between trained and control
mice in either the hippocampus [F(1,4)=7.39; p,0.01] or amygdala
[F(1,4)=9.07; p,0.01], but not in the cortex. Post-hoc tests revealed
significant differences (p,0.05 or 0.01) between trained group and
every control group, but not between any two control groups. For the
total eEF-2 level (phospho-eEF-2 and dephospho-eEF-2), neither an
Figure 1. Gene expression profiles in the hippocampus of B6/
CBA F1 mice following the training in FCT. A time-course of 30,
60, and 120 min (m) was examined. Over 100 probes that detected
mRNAs that encode to transcriptional machineries or their related
molecules and neuronal activity were used. No significant change in the
expression level of translational machineries or their related molecules
was found, whereas a number of neuronal activity-related genes were
either up- or down-regulated, of which many immediate-early genes
were up-regulated.
doi:10.1371/journal.pone.0007424.g001
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training in a fear-conditioning test.
Gene Name Profiles
eukaryotic translation initiation factor 3 (Eif3) 0.8
eukaryotic translation initiation factor 4E binding protein 2 (Eif4ebp2) 1.2
eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked (Eif2s3y) 1.1
eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1) 0.9
eukaryotic translation initiation factor 2, subunit 2 (beta, 38kDa) 1.0
Similar to eukaryotic translation initiation factor 3, subunit 4 (delta, 44kD) 1.0
eukaryotic translation initiation factor 2A (Eif2a) 1.5
eukaryotic translation initiation factor 2 alpha kinase 4 (Eif2ak4) 1.2
eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked (Eif2s3x) 1.5
heme-regulated eIF2 alpha kinase (Hri) 1.1
eukaryotic translation initiation factor 2 alpha kinase 1 1.0
eukaryotic translation initiation factor 2 alpha kinase 2 1.8
eukaryotic translation initiation factor 4E 1.0
eukaryotic translation initiation factor 1A 1.1
eukaryotic translation initiation factor 3, subunit 5 (epsilon) 1.0
eukaryotic translation initiation factor 4A1 1.1
Highly similar to e2be rat translation initiation factor eIF-2B epsilon subunit 1.0
eukaryotic translation initiation factor 3, subunit 3 (gamma, 40kD) 0.4
eukaryotic translation initiation factor 4E binding protein 1 1.4
eukaryotic translation initiation factor 4A1 1.0
eukaryotic translation initiation factor 4E binding protein 2 0.9
eukaryotic translation initiation factor 5A 1.0
eukaryotic translation initiation factor 4A2 1.0
eukaryotic translation initiation factor 3, subunit 2 (beta, 36kD) (Eif3s2) 1.1
eukaryotic translation initiation factor 3 1.1
eukaryotic translation initiation factor 2, subunit 2 (beta, 38kDa) (Eif2s2) 1.1
eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3) 1.0
eukaryotic translation initiation factor 2B (Eif2b) 1.2
eukaryotic translation initiation factor 4E 1.1
eukaryotic translation initiation factor 4A2 1.0
eukaryotic translation initiation factor 5A 1.0
Mouse RNA-dependent EIF-2 alpha kinase 1.8
eukaryotic translation initiation factor 2A 1.2
eukaryotic translation initiation factor 2 alpha kinase 1 1.3
eukaryotic translation initiation factor 4E binding protein 2 1.1
eukaryotic translation initiation factor 3, subunit 8 (110 kDa) 0.9
eukaryotic translation initiation factor 2, subunit 2 (beta, 38kDa) 1.0
Highly similar to S72266 translation initiation factor eIF2B gamma chain 0.9
eukaryotic translation initiation factor 5A2 1.3
eukaryotic translation initiation factor 3, subunit 8 (110 kDa) (Eif3s8) 1.1
eukaryotic translation initiation factor 3, subunit 8 (110 kDa) 0.9
eukaryotic translation initiation factor 4, gamma 2 (Eif4g2) 1.1
eukaryotic translation initiation factor 3, subunit 3 (gamma, 40kD) (Eif3s3) 1.0
eukaryotic translation initiation factor 3, subunit 7 (zeta, 6667 kDa) (Eif3s7) 0.8
eukaryotic translation initiation factor 3, subunit 2 (beta, 36kD) (Eif3s2) 0.9
eukaryotic elongation factor, selenocysteine-tRNA-specific (Eefsec) 1.3
eukaryotic translation elongation factor 1 alpha 2 (Eef1a2) 0.9
eukaryotic translation elongation factor 1 alpha 1 0.9
eukaryotic translation elongation factor 2 1.0
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(Figure 2C and F) was noted in the hippocampus (Figure 2A and C),
amygdala (Figure 2D and F), or cortex (data not shown) between
trained and control mice. Moreover, at 2 hr after the training, a very
similar pattern of dephopho-eEF-2 and the total eEF-2 level to those
observed at 30 min after the training was found in both the
hippocampus and amygdala, together with no any significant change
in both of the dephopho-eEF-2 and total eEF-2 level in the cortex (data
not shown). Four hours after the training, the dephospho-eEF-2 in the
hippocampus (Figure 2G and H) and amygdala (Figure 2G and I)
returned to the pre-training level, indicating that there was a time
window for the dephosphorylation. Similarly, the phospho-eEF-2 in
the cortex and the total eEF-2 level in all these three brain regions were
not significantly different between trained and control mice. All these
results indicated that the dephospho-eEF-2, but not the change in its
expression level, in both the hippocampus and amygdala was
temporally but significantly associated with post-training while this
change was not noted in the cortex.
MK-801 concurrently blocked memory consolidation and
post-training dephospho-eEF-2
Post-training dephospho-eEF-2 provided a clue for us to explore
whether this change served as a working mechanism for memory
consolidation. We first addressed whether there was a functional link.
Based on the essential role of the NMDA receptor in memory
consolidation [25,26], we examined whether antagonism of NMDA
receptors could block both memory consolidation and dephospho-
eEF-2. Mice were treated with MK-801 (0.2 mg/kg; i.p.) immediately
following the training, and memory retention and phospho-eEF-2 were
examined 2 hr thereafter. To exclude an acute effect of MK-801,
another group of mice was examined for their memory retention 24 hr
after the treatment. As expected, mice treated with MK-801 were
significantly impaired in both contextual and cued conditionings at
either 2 hr (Figure 3A and B) or 24 hr (data not shown), compared to
those in mice treated with vehicle (p,0.01; Student’s t test). Since the
treatment (i.p.) lacked a brain region-specificity, the overall mnemonic
function was affected. Based on our previous findings [25] and others
[27,28], together with the effect observed at 24 hr here, this
impairment should attribute to a deficit in memory consolidation.
Very interestingly, the same MK-801-treatment prevented the post-
training dephospho-eEF-2 in the hippocampus (Figure 3C) and
amygdala (Figure 3E) at 2 hr after the treatment. A statistical
significance was observed in the hippocampus (Figure 3D; p,0.01;
Student’s t test) and amygdala (Figure 3E; p,0.01; Student’s t test)
between MK-801-treated trained mice and vehicle-treated trained
mice, as well as between trained mice and naı ¨ve mice (p,0.01;
Student’s t test). This concurrent effect on memory consolidation and
post-training dephospho-eEF-2 strongly suggested a functional link
between these two events, because the blockade of NMDA receptors
was able to block both of them.
Generation of hippocampus-specific eEF-2K transgenic
(hip-eEF-2K-tg) mice
The functional link between the dephospho-eEF-2 and memory
consolidation conferred an opportunity to further study whether a
blockade of the dephospho-eEF-2 following training impaired
memory consolidation via blocking protein synthesis. Based on the
findings that (1) eEF-2K is the most important kinase that
phosphorylates and inactivates eEF-2, (2) the only identified
substrate for eEF-2K is eEF-2 [23,26], and (3) training in the FCT
in the mouse creates two types of conditionings that are
respectively hippocampus-dependent and -independent, to over-
express eEF-2K in the hippocampus only would provide an ideal
system to specifically analyze whether the post-training depho-
spho-eEF-2 plays a role in memory consolidation. Accordingly, a
Cre/loxP recombination system and a transcriptional silencing
strategy were used to generate hip-eEF-2K-tg mice. Two
independent transgenic mouse strains, eEF-2K transgenic mice
and Cre transgenic mice, were needed (Figure S1). The eEF-2K
transgenic mice were featured by Cre recombination-dependent
deletion of a transcriptional stop signal that located upstream of
the eEF-2K transgene so that the transgene would only express in
the cells or brain region where Cre expressed. Fortunately, as the
Cre expression in our Cre transgenic mice was limited to neurons
in most parts of the hippocampus, Cre/eEF-2K double transgenic
mice exhibited hippocampus-specific eEF-2K overexpression,
which was evidenced by in situ hybridization (Figure 4A to D).
The highest level of the transgene mRNA was observed in the
CA1/CA3 regions, a lower level in the dentate gyrus, and little
expression in the CA2 region (Figure 4D). Real-time RT-PCR
showed a 10-fold higher level of the total eEF-2K mRNAs
(endogenous and transgenic eEF-2K) in the hippocampus of hip-
eEF-2K-tg mice than in wild-type mice (data not shown), whereas
Western blot analysis showed a 5.5-fold higher level of eEF-2K
protein in the hippocampus of hip-eEF-2K-tg mice than in wild-
type mice (Figure 4E, upper panel and F). Moreover, a
significantly higher level (about 2.5-fold) of phospho-eEF-2 was
observed in the hippocampus of hip-eEF-2K-tg mice, compared to
that in wild-type mice (Figure 4E middle panel and Figure 4G). A
tendency of decrease in the total eEF-2 expression was observed in
hip-eEF-2K-tg mice (Figure 4E low panel) but was not statistically
significant. In the cortex and amygdala, no observable difference
in the expression of eEF-2K, phospho-eEF-2, or the total eEF-2
was found between wild-type and hip-eEF-2K-tg mice (data not
shown). These results indicated that we successfully generated hip-
eEF-2K-tg mice and the eEF-2K transgene was functional.
Overall characterization of hip-eEF-2K-tg mice
To exclude a possibility that a random insertion of a transgene
into the mouse genome might produce some unexpected effects,
the general conditions of the transgenic mice were carefully
Gene Name Profiles
eukaryotic translation elongation factor 1 beta 2 1.0
eukaryotic translation elongation factor 1 beta 2 (Eef1b2) 1.0
eukaryotic elongation factor-2 kinase 1.2
eukaryotic translation elongation factor 1 epsilon 1 (Eef1e1) 1.1
eukaryotic translation elongation factor 1 delta 1.0
doi:10.1371/journal.pone.0007424.t001
Table 1. Cont.
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observable abnormality in growth, body size, and mating, eating,
and general behaviors, compared to those in their wild-type
littermates (data not shown). Nissl staining and Golgi-impregnated
staining did not reveal an observable difference between wild-type
(Figure 4H) and hip-eEF-2K-tg mice (Figure 4I). Open-field
behaviors indexed by movement time, total distance traveled, and
rearing numbers were indistinguishable between these mice
(Figure S2A-C). These results indicated that overall hip-eEF-2K-
tg mice were similar to their wild-type littermates.
Figure 2. Dephospho-eEF-2 in both the hippocampus and amygdala is temporally associated with post-training. A. Representative
Western blots showing the expression level of phospho-eEF-2 (phosph eEF-2; upper panel), total eEF-2 (middle panel), and b-actin (low panel) in
hippocampi from mice that were sacrificed 30 min after the training. NC: naı ¨ve control; SC: shock control; CC: contextual control; TC: tone control;
FCT: fear-conditioning training. B. Quantitative analysis of phospho-eEF-2 in hippocampi from mice that were sacrificed 30 min after the training
(n=5), in comparison to NC (n=6), SC (n=5), CC (n=5), and TC (n=5). C. Quantitative analysis of the total eEF-2 level in hippocampi of the same
mice as described in B. D. Representative Western blots showing the expression level of phospho-eEF-2 (phosph eEF-2; upper panel), total eEF-2
(middle panel), and b-actin (low panel) in amygdalae from the same mice as described in B. E. Quantitative analysis of phospho-eEF-2 in amygdalae
from the same mice as described in B. F. Quantitative analysis of the total eEF-2 level in amygdalae of the same mice as described in B. G.
Representative Western blots showing the expression level of phospho-eEF-2 (phosph eEF-2; upper panel), total eEF-2 (middle panel), and b-actin
(low panel) in both hippocampi (Hip) and amygdalae (Amy) from mice that were sacrificed 4 hr after the training. (H). Quantitative analysis of
phospho-eEF-2 in hippocampi from NC (n=6) and trained mice (n=5) that were sacrificed 4 hr after the training in FCT. (H). Quantitative analysis of
phospho-eEF-2 in amygdalae from the same mice as described in H. **, p,0.01, one-way ANOVA.
doi:10.1371/journal.pone.0007424.g002
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transgene specifically inhibited protein synthesis in the
hippocampus, but not any other brain regions
We then asked whether the increased phospho-eEF-2 affected
protein synthesis. First, we used an in vivo [35S]-methionine
labeling system [29] to examine the rate of [35S]-methionine
incorporation into new proteins in the brain. As shown in
Figure 5A, the [35S] incorporation in hippocampi from hip-eEF-
2K-tg mice was slightly, but significantly, lower than in wild-type
mice (p,0.05; Student’s t test); whereas in either cortices (data not
shown) or amygdalae (Figure 5A), no significant difference was
found. In should be noted that as the assay was conducted with the
lysates from the whole hippocampus that contained cells that
expressed very little of the transgene (CA2 neurons) or that did not
express the transgene at all (all glial cells), the results showed in
Figure 5A did not represent the overall protein synthesis inhibition
rate in all hippocampal neurons. This was also evidenced by
autoradiography, which showed the lowest density of [35S]-
labeling in the CA1/CA3 regions, a fairly low level in the dentate
gyrus, and almost no change in the CA2 region of hip-eEF-2K-tg
mice (Figure 5E and F), compared to those in wild-type mice
(Figure 5B and C). Similarly, no observable changes could be
detected in any other brain regions including the amygdala
(Figure 5D and G) and cortex (Fig. 5B and E), confirming the
hippocampus-specific effect. The pattern of the protein synthesis
inhibition in different hippocampal sub-regions was almost the
same as that in the transgene mRNA expression (Figure 4D). It
Figure 3. Effect of MK-801 on post-training dephospho-eEF-2 and memory retention. A. Contextual conditioning 2 hr after training/MK-801
treatment.**,p,0.01,Student’s t test.Imm:immediatefreezing;cont cond:contextualconditioning.B.Cuedconditioningmemory inthesamemice.**,
p,0.01, Student’s t test. cued cond: cued conditioning. C. Expression level of phospho-eEF-2 (phosph) in hippocampi from mice 2 hr after training/MK-
801 treatment. 1: naı ¨ve control; 2: mice with training/vehicle; 3: mice with training/MK-801. D. Quantitative analysis of the expression of phospho-eEF-2
in hippocampi from mice 2 hr after the training. **, p,0.01; Student’s t test, compared between trained group-treated with vehicle and either naı ¨ve
group or trained group-treated with MK-801. E. The expression level of phospho-eEF-2 (phosph) in amygdalae from mice 2 hr after the training. The
same mice, as described above, were used. F. Quantitative analysis of the expression of phospho-eEF-2 in amygdalae of mice 2 hr after training. **,
p,0.01; Student’s t test, compared between trained group-treated with vehicle and either naı ¨ve group or trained group-treated with MK-801.
doi:10.1371/journal.pone.0007424.g003
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transgene expression was at the highest level, the [35S]-labeling
signal was still observable, indicating that protein synthesis was not
completely diminished by the transgene.
We further employed a dynamic modeling system to evaluate
the transgene effect. It has been well known that the expression of
certain immediate-early genes such as Arc and c-fos can be quickly
triggered by neuronal activities [30,31]. To compare the difference
between the mRNA transcription and protein translation in the
same brain region of the same animal or between different animals
provided a valuable means to analyze how the protein synthesis
was specifically affected by the transgene. Accordingly, mice were
either treated with vehicle (basal level, BL) or a single dose of
kainic acid (KA; 20 mg/kg; i.p.), and then brains were collected
with a time-course from 5 min to 3 hr. A robust induction of both
Arc and c-fos mRNAs was observed in the hippocampus, with a
peak at 60 min for Arc mRNA in either wild-type (Figure 5H) or
hip-eEF-2K-tg mice (Figure 5I) and a peak at 30 min for c-fos
Figure 4. Generation of hip-eEF-2K-tg mice. A-D in situ hybridization showing the expression of the eEF-2K transgene in wild-type (A) and hip-
eEF-2K-tg mice (C) or a higher magnification in wild-type (B) and hip-eEF-2K-tg mice (D). Exclusive expression of the transgene mRNA was found in
the CA1, CA3, and dentate gyrus, but not the CA2 region. E. Representative Western blots showing the expression of the total eEF-2K (including the
endogenous and transgenic eEF-2K; upper panel), phospho-eEF-2 (phosph) (middle panel), and the total eEF-2 (including phospho- and dephospho-
eEF-2; low panel) in the hippocampi from wild-type (wt) and hip-eEF-2K-tg (tg) mice. F. Quantitative analysis of the expression of eEF-2K in wt (n=6)
and tg mice (n=5). ***, p,0.001, Student’s t test. G. Quantitative analysis of the expression of phospho-eEF-2 in wt (n=5) and tg mice (n=5). **,
p,0.01, Student’s t test. H and I. Representative microphotography of Nissl staining and Golgi staining in wild-type (h) and hip-eEF-2K-tg mice (i).
doi:10.1371/journal.pone.0007424.g004
eEF-2 and Memory Consolidation
PLoS ONE | www.plosone.org 7 October 2009 | Volume 4 | Issue 10 | e7424Figure 5. Protein synthesis inhibition in the hippocampus, but not amygdala, of hip-eEF-2K-tg mice. A. Quantitative analysis of [
35S]-
methionine incorporation into proteins in the hippocampi (hipp) and amygdalae (amy) from wild-type (wt; n=6) and hip-eEF-2K-tg (tg) mice (n=7).
*, p,0.05, Student’s t test. B and E. Representative autoradiography microphotographs showing protein synthesis inhibition in coronal brain sections
from wild-type (B) and hip-eEF-2K-tg mice (E). C and F. A higher magnification of microphotographs showing protein synthesis inhibition in the
hippocampus of hip-eEF-2K-tg mice (F), compared to wild-type mice (C). D and G. A higher magnification of microphotographs showing no
observable protein synthesis inhibition in the amygdala of hip-eEF-2K-tg mice (G) compared to wild-type mice (D). H and I. Expression of Arc mRNA
(black line) and Arc protein (red line) in the hippocampi from wild-type (H; n=5 in each group) and hip-eEF-2K-tg mice (I; n=5 in each group). BL:
basal line from mice treated with vehicle. J and K. Expression of c-fos mRNA (black line) and c-Fos protein (red line) in the hippocampi from wild-type
(J; n=4 in each group) and hip-eEF-2K-tg mice (K; n=4 in each group). BL: basal line from mice treated with vehicle. L and M. Quantitative analysis of
the expression of Arc protein (L) and c-Fos protein (M) in hippocampi from mice after KA injection at the average level and peak level. *, p.0.05,
Student’s t test, ***, p,0.001, post hoc test, compared between wild-type (wt) and hip-eEF-2K-tg (tg) mice.
doi:10.1371/journal.pone.0007424.g005
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(Figure 5K). For a within-genotype analysis between vehicle- and
KA-treated mice, we found a highly significant difference in Arc
mRNA expression in either wild-type [F(5,25)=6.24, p,0.001] or
hip-eEF-2K-tg mice [F(5,25)=10.34, p,0.001], and in c-fos
mRNA expression in either wild-type [F(5,20)=29.34, p,0.001]
or hip-eEF-2K-tg mice [F(5,20)=31.29, p,0.001]. A between-
genotype analysis with a repeated ANOVA did not reveal a
significant difference in the expression of either mRNA in these
mice, indicating that the transgene did not affect the transcriptions
of the mRNAs that were associated with neuronal activity. At the
protein level, a delayed but similar expression pattern for both Arc
and c-Fos was observed (red line; Figure 5H-K). In KA-treated
wild-type mice, an one-way ANOVA confirmed the increase in
both Arc expression [F(4,20)=8.01, p,0.001] and c-Fos expres-
sion [F(4,15)=37.88, p,0.001]. In KA-treated hip-eEF-2K-tg
mice, the increase in the expression of either Arc [F(4,20)=3.27,
p,0.05] or c-Fos [F(4,15)=4.65, p,0.05] was at a less significant
level. Moreover, a repeated ANOVA revealed a highly significant
difference in the expression of Arc [F(4,40)=9.69, p,0.001] or c-
Fos [F(4,30)=39.79, p,0.001] between wild-type and hip-eEF-
2K-tg mice, confirming the effect of the transgene on protein
synthesis inhibition. The p values at the average level from four
time-points of the time-course (p,0.05) and at the peak level
(p,0.001) were different in either Arc (Figure 5L) or c-Fos
expression (Figure 5M), indicating that the effect of the transgene
was more robust during an ‘‘on-going’’ protein synthesis process.
Expression of the eEF-2K transgene prevented
post-training dephospho-eEF-2 in the hippocampus
Before the training in the FCT, the phospho-eEF-2 level in the
hippocampus (Figure 6A), but not the amygdala (Figure 6D), of
hip-eEF-2K-tg mice was higher than that in wild-type mice. Thirty
minutes after the training, the phospho-eEF-2 level significantly
decreased (p,0.05; Student’s t test) in both the hippocampus
(Figure 6A and B) and amygdala (Figure 6D and E), without a
significant change in the total eEF-2 level in either group
(Figure 6C and F). Interestingly, a significant difference in the
phospho-eEF-2 level was still observed in the hippocampus
(Figure 6B and H; p,0.05; Student’s t test), but not the amygdala
(Figure 6E and K), between trained wild-type and trained hip-
eEF-2K-tg mice, indicating that the effect was due to the transgene
expression. Similar changes were observed in mice sacrificed at
2 hr after the training (Figure 6G-L). These results indicate that
the transgene was able to largely, but not completely, prevent post-
training dephospho-eEF-2 in the hippocampus, but not amygdala.
Long-term hippocampus-dependent memory was
specifically impaired in hip-eEF-2K-tg mice
The results above validated an ideal system to test whether the
post-training dephospho-eEF-2 was functionally associated with
memory consolidation. In order to exclude a non-specific effect of
Figure 6. Overexpression of eEF-2K in the hippocampus
prevented post-training dephospho-eEF-2. A-F. Expression of
phospho-e-EF-2 in mice 30 min after the training. A. Representative
Western blots showing the expression level of phospho-eEF-2 (phosph;
upper panel) and total eEF-2 (low panel) in the hippocampi from wild-
type (wt) and hip-eEF-2K-tg (tg) mice 30 min after training (trained) or
without training (naı ¨ve). B. Quantitative analysis of the expression level
of phospho-eEF-2 in hippocampi 30 min after the training. **, p,0.01,
naı ¨ve wt mice vs. naı ¨ve tg mice; @, p,0.05, naı ¨ve wt mice vs. trained wt
mice. #,p ,0.05, naı ¨ve tg mice vs. trained tg mice; *, p,0.05, trained wt
mice vs. trained tg mice. nv: naı ¨ve; tn: trained. C. Quantitative analysis
of the expression level of the total eEF-2 in hippocampi 30 min after the
training. D. Representative Western blots showing the expression level
of phospho-eEF-2 (upper panel) and total eEF-2 (low panel) in the
amygdalae of wt and tg mice 30 min after the training and without
training. E. Quantitative analysis of the expression level of phospho-
eEF-2 in amygdalae 30 min after the training. @, p,0.01, naı ¨ve wt mice
vs. trained wt mice. #,p ,0.05, naı ¨ve tg mice vs. trained tg mice. F.
Quantitative analysis of the expression level of the total eEF-2 in
amygdalae 30 min after the training. G-I. Expression of phospho-e-EF-2
in tg mice 2 hr after the training. G. Representative Western blots
showing the expression level of phospho-eEF-2 (upper panel), total eEF-
2 (middle panel), and b-actin (low panel) in hippocampi 2 hr after the
training and without training. H. Quantitative analysis of the expression
level of phospho-eEF-2 in hippocampi 2 hr after the training. **,
p,0.01, naı ¨ve wt mice vs. naı ¨ve tg mice; @, p,0.05, naı ¨ve wt mice vs.
trained wt mice. #,p ,0.05, naı ¨ve tg mice vs. trained tg mice; *, p,0.05,
trained wt mice vs. trained tg mice. I. Quantitative analysis of the
expression level of the total eEF-2 in hippocampi of mice 2 hr after the
training. J. Representative Western blots showing the expression level
of phospho-eEF-2 (upper panel), total eEF-2 (middle panel), and b-actin
(low panel) in amygdalae 2 hr after the training and without training. K.
Quantitative analysis of the expression level of phospho-eEF-2 in
amygdalae of mice 2 hr after the training. @, p,0.01, naı ¨ve wt mice vs.
trained wt mice. #,p ,0.05, naı ¨ve tg mice vs. trained tg mice. L.
Quantitative analysis of the expression level of the total eEF-2 in
amygdalae of mice 2 hr after the training. Sample size in each group
was 4–5 mice, with at least 2 measures in each animal. Student’s t test
was used for all statistical analyses.
doi:10.1371/journal.pone.0007424.g006
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protein synthesis inhibition specifically affected long-term memo-
ry, both short-term and long-term memories were examined. At
30 min after the training, freezing response in contextual
(Figure 7A) and cued conditioning (Figure 7D) was at the same
level between wild-type and hip-eEF-2K-tg mice, indicating that
the contextual and cued short-term memories were intact in hip-
eEF-2K-tg mice. Long-term memory was examined at 1 day and
10 days after the training with two separate sets of mice.
Compared to that in wild-type mice, a lower freezing rate was
observed in eEF-2K-tg mice in contextual (Figure 7B and C;
p,0.001; Student’s t test), but not cued conditioning (Figure 7E
and F), in both retention tests, indicating that long-term
hippocampus-dependent memory, but not hippocampus-indepen-
dent memory, was impaired. To exclude a possibility that a
different nociceptive response might contribute to the difference
above, the minimal amount of current required to produce
stereotypical behaviors (flinching/running, jumping, and vocaliz-
ing) was measured after the retention tests, and the results did not
show any significant difference between these mice (data not
shown).
In order to determine whether the hippocampus-specific protein
synthesis inhibition affected other types of hippocampus-depen-
dent memory, spatial learning and memory were evaluated by
using a Morris water-maze test [32,33]. Mice were trained with a
five-day training protocol. In both wild-type and hip-eEF-2K-tg
Figure 7. Long-term, but not short-term, hippocampus-dependent memory is impaired in hip-eEF-2K-tg mice. A. Short-term memory
in contextual conditioning was measured at 30 min after the training. No significant difference was observed in either immediate (imm) freezing after
shock or contextual conditioning (cont condi) between wild-type (wt, n=10) and hip-eEF-2K-tg mice (tg, n=13). B. Short-term memory in cued
conditioning was measured at 30 min after the training. No significant difference was observed in either pre-tone freezing or cued conditioning
(cued condi) between wt (n=10) and tg mice (n=13). C. Long-term memory in contextual conditioning was measured at 1 day after training. While
no significant difference was observed in immediate freezing after shock, a highly significant difference was found in contextual conditioning
between wt (n=10) and tg mice (n=12). ***, p,0.001, Student’s t test. D. Long-term memory in cued conditioning was measured at 1 day after
training. No significant difference was observed in either pre-tone freezing or cued conditioning. E. Long-term memory in contextual conditioning
was measured at 10 days after the training. While no significant difference was observed in immediate freezing after shock, a highly significant
difference was found in contextual conditioning between wt (n=11) and tg mice (n=12). ***, p,0.001, Student’s t test. F. Long-term memory in
cued conditioning was measured at 10 days after training. No significant difference was observed in either pre-tone freezing or cued conditioning. G.
Learning curve in a water maze test; repeated ANOVA did not reveal a significant difference between wt (n=11) and tg (n=12) mice. H. Time spent in
the target quadrant in a probe test 24 hr after the completion of the training sessions. *, p,0.05, Student’s t test. i. Number of crossing over the
platform location in the probe test 24 hr after the completion of the training session. *, p,0.05, Student’s t test.
doi:10.1371/journal.pone.0007424.g007
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training (Figure 7G), and cross-sectional analyses with an one-way
ANOVA revealed a highly significant difference in the latency in
either wild-type [F(4,50)=6.74, p,0.001] or hip-eEF-2K-tg mice
[F(4,55)=7.59, p,0.001]. Moreover, a repeated ANOVA did not
reveal any significant difference between these two groups,
indicating that all these mice could equally learn the task. In a
probe test, however, a significant difference (p,0.05; Student’s t
test) in the amount of time spent in the target quadrant (Figure 7H)
or in the number of crossing the area that represented the location
of the platform previously placed during the training sessions
(Figure 7I) was observed, indicating that the transgenic mice were
impaired in spatial retention. Since the learning curve (training
sessions) represents a compound effect of acquisition and retention,
with a dominant influence from the acquisition, a normal learning
curve in hip-eEF-2K-tg mice indicates an intact acquisition
process. On the other hand, the probe test detects the ‘‘pure’’
retention of the spatial navigation, and a deficit in this test provides
additional evidence that these transgenic mice are impaired in
long-term hippocampus-dependent (spatial) memory.
Late-phase LTP (L-LTP) was impaired in the hippocampus
of hip-eEF-2K-tg mice
LTP, a cellular model for learning and memory, may also be
divided into different phases. Evidence indicates that these
different phases perfectly fit into memory stages [34]. Early-phase
LTP, which is protein synthesis-independent, correlates to short-
term memory, whereas L-LTP, which is protein synthesis-
dependent, correlates to long-term memory [35,36]. Therefore,
it is important to examine whether the inhibition of protein
synthesis affected L-LTP. As shown in Figure 8A, 4 trains of high-
frequency stimulation (100 Hz for 1 second) were used to produce
L-LTP in the hippocampal Schaffer collateral/commissural
pathway. As shown in Figure 8B, it was apparently that the
post-tetanic potentiation in hip-eEF-2K-tg slices was not signifi-
cantly different from that in wild-type slices. This also indicated
that the basal synaptic transmission was similar in all these mice.
However, quantitative analyses revealed a highly significant
difference between wild-type and hip-eEF-2K-tg slices from
90 min up to the whole observation period (180 min), whereas
no significant difference was observed in LTP production (peak) or
LTP maintenance before 90 min. These results indicated that L-
LTP was specifically and significantly impaired in hip-eEF-2K-tg
mice.
Discussion
In this study, we first found that dephospho-eEF-2 in both the
hippocampus and amygdala of mice was temporarily associated
with post-training, whereas no any significant change in the
expression of the mRNAs for translational machineries or their
related molecules could be identified. The use of MK-801 then
revealed that both post-training dephospho-eEF-2 and memory
consolidation were neuronal activity-dependent, and that there
was a functional link between these two events. At the last, by
using a unique transgenic mouse model, we have documented that
the post-training dephospho-eEF-2 is a molecular underpinning
for protein synthesis pertinent to memory consolidation.
New protein synthesis is required for various forms of long-
lasting synaptic plasticity. Although the exact mechanisms might
be different in different forms of plasticity, protein synthesis itself is
basically under the control of both the transcriptional and
translational actions. At the transcriptional level, the expression
of mRNAs may directly affect protein synthesis at a number of
ways. For example, a changed expression level of the translational
machineries or their related molecules such as a up-regulation of
mTOR [37] or a down-regulation of eEF-2K [38] may facilitate
the overall translational activity. However, our genome-wide
screening study did not reveal any evidence to support that this is
the case for memory consolidation. Another way is that the
expression of certain mRNAs may directly lead to new protein
synthesis. We indeed found that the expression of certain genes
such as c-fos and BDNF was up regulated following the behavioral
training, which is consistent with many other studies [39,40].
Because the expression of c-fos and BDNF is critically involved in
memory formation [41,42], and because most of these up-
regulated transcripts may be further processed for protein
synthesis, the expression of these genes may certainly contribute
to memory consolidation. However, evidence indicates that the
expression of these non-translational machinery-related molecules
is unable to fully explain how protein synthesis is regulated for
memory consolidation [43,44].
The finding that the training facilitates dephospho-eEF-2 sheds
light on a new translational mechanism, which has been validated
from several angles in this study. First, the dephospho-eEF-2 is
coincided in the hippocampus and amygdala, both brain regions
are importantly involved in consolidating fear memories [24].
Second, the post-training antagonism of NMDA receptors is able
to concurrently block the dephosphorylation and memory
consolidation, indicating a functional link between them. Third,
as the NMDA receptor is the most important excitatory machinery
in the brain, this concurrent effect indicates that both the post-
training dephospho-eEF-2 and memory consolidation are neuro-
nal activity-dependent, which is also supported by other reports
[25,45–47]. Fourth, blockade of the dephospho-eEF-2 by the eEF-
2K transgene dramatically inhibits protein synthesis, and this
effect is more robust during an ongoing protein synthesis process
that is associated with neuronal activity (Figure 5). Given that both
neuronal activity and protein synthesis are critically involved in
memory consolidation [15,24,25], a stronger effect during an
ongoing protein synthesis process than during the general
conditions provides a basis to identify whether a dynamic process
of protein synthesis is more importantly required for memory
consolidation. Indeed, we found that while these transgenic mice
looked undistinguishable from their wild-type littermates at the
overall level (Figure S2), both L-LTP and long-term hippocampus-
dependent memory were significantly impaired (Figure 7 and
Figure 8). All these results indicate that the post-training depho-
spho-eEF-2 plays a critical role in triggering memory consolida-
tion-associated protein synthesis.
It should be mentioned that previous studies have found that the
phospho-eEF-2 occurs within 15 min following the activation of
NMDA receptors, and this phosphorylation is accompanied by
protein synthesis inhibition [45,48]. In contrast, we found here
that the antagonism of NMDA receptor led to phospho-eEF-2 at
2 hr after the treatment. Therefore, we suggest that there might be
two distinct phases, an early phase of phospho-eEF-2 and a late
phase of dephospho-eEF-2, following the activation of NMDA
receptors. Indeed, a late phase of dephospho-eEF-2, together with
an enhanced overall protein synthesis, was found in those previous
studies too [45,48]. This ‘‘two-phase theory’’ may explain why the
phospho-eEF-2 and inhibition of protein synthesis were observed
within 1 hr after LTP production in the hippocampus [49], while
in our study, it is supposingly that the L-LTP (after 3 hr) should be
featured by an increase in dephospho-eEF-2. Another issue is
about the effect of phospho-eEF-2. Although the overall protein
synthesis is inhibited after the phospho-eEF-2, the expression of
several specific molecules including Ca
2+-calmodulin-dependent
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which is inconsistent to our results (Figure 5). Given that (1) the
increase of CaMK-II is found at the synaptic level [48]; (2) the
expression of Arc and c-Fos may facilitate transcriptions of other
genes; and (3) the increase of the translation of Arc and c-Fos
occurs at the early phase of the phospho-eEF-2, a ‘‘synaptic
competition’’ theory[48] might explain for this discrepancy, that is
the up-regulation of Arc and c-Fos in their studies may represent a
competitive mechanism for a late phase enhancement of protein
synthesis. In our transgenic mice, as the transgene is constitutively
expressed and as the phospho-eEF-2 is persistently higher, this
compensative mechanism no longer exists, and thus the translation
of Arc and c-Fos is inhibited. Regarding why a protein synthesis
inhibitor could block early-phase LTP [50,51], while the deficit in
our transgenic mice was only observed at the L-LTP, it might be
due to a different neuronal activity between these different
conditions. The use of a protein synthesis inhibitor is generally
accompanied by a higher synaptic function [52], while in our
transgenic mice, the synaptic function may be persistently lower
due to the constitutive transgene expression and thus, we could not
identify a significant effect on the early-phase LTP.
Another important insight from the current study is that our
study has demonstrated the requirement of new protein synthesis
for memory consolidation from different angles. As described
above, the role of protein synthesis in memory consolidation was
originally established based on pharmacological studies with
protein synthesis inhibitors [14,15,53]. Because the inhibitors are
able to break the ‘‘chain’’ of the protein synthesis reaction, protein
synthesis cannot be completed, which, in turn, renders the process
of consolidation impaired. Virtually, all of those studies were
essentially looking at the ‘‘consequences after the chain is broken’’,
but could not look into ‘‘how the chain works under the normal
Figure 8. L-LTP, but not post-tetanic potentiation, is impaired in the hippocampus of hip-eEF-2K-tg mice. A. Four trains of high-
frequency stimulation (100 Hz for 1 second) made the fEPSP still robust measured at 180 min after the stimulation in wild-type (wt) slices but not in
transgenic (tg) slices. B. Quantitative analysis of the potentiation during this 180 min period indicated that there was no significant difference in LTP
production (peak) and LTP maintenance before 90 min, whereas there was a highly significant difference exhibited from 90 min up to the whole
observation period.
doi:10.1371/journal.pone.0007424.g008
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have revealed some new insights. For example, either pharmaco-
logically [54,55] or genetically [56] blocking mTOR in the
animals impairs memory consolidation. However, those studies are
essentially similar to the pharmacological studies described above
since those studies could not identify an active process that triggers
protein synthesis for memory consolidation. In contrast, depho-
spho-eEF-2 following the behavioral training represents an active
molecular process in the brain, and blocking this process leads to
impairments in both L-LTP and long-term memory formation.
Why eEF-2 is dephosphorylated following the behavioral
training is still unclear. Based on the findings that dephospho-
eEF-2 is neuronal activity-dependent [45–47,57], together with
our findings that antagonism of NMDA receptors prevents both
dephospho-eEF-2 and memory consolidation, we have reasons to
speculate that this dephosphorylation is learning-triggered neuro-
nal activity-dependent. Previous studies did find that phosphory-
lation of mTOR and p70S6 kinase was increased following
training, but they could not demonstrate whether the phosphor-
ylation itself was essential, since they did not have an approach to
specifically block the phosphorylation in the brain [58]. Based on
the role of both eIF and eEF in protein synthesis, the dephospho-
eEF-2 might not be the only mechanism. Recent evidence indeed
indicated that phosphorylation/dephosphorylation of eIF was
importantly involved in memory consolidation, while the results
were inconsistent. Reduced phosphorylation of eIF2a by point
mutation or by knocking out GCN2 (an eIF2a inhibitor) enhanced
and impaired long-term memory, respectively [46,59,60], indicat-
ing that either the role of eIF is still unclear or that there may be a
bi-directional role for phosphorylation of eIF in regulating protein
synthesis [59]. In contrast, our studies have consistently shown the
role of post-training dephospho-eEF-2 in memory consolidation
from the behavioral, pharmacological, and genetic levels.
Importantly, as eEF-2K-mediated phospho-eEF-2 is a major
mechanism for the control of the rate of protein synthesis [23],
post-training dephospho-eEF-2 may represent a fundamental
mechanistic process that leads other translation mechanisms to
promote protein synthesis for consolidation of newly learned
information.
We need to point out that the effects of the transgene in the
current study do not actually indicate the role of a single gene in
memory consolidation, and do not essentially explore the role of a
genetic basis for learning and memory in this study, as many other
studies did [61], [62]. The high expression level of the transgene
should not be a ‘‘physiological condition’’ in anyway. However,
this high expression level could be used as a tool to prevent
training-induced dephospho-eEF-2 in a specific brain region–the
hippocampus. The results of this blockage suggested that there
might be a mechanism that works at the network level to control
the process of learning and memory, especially memory
consolidation [63]. The answer to this question will be the next
topic of our study.
Materials and Methods
All the experiments for the use of mice were performed
according to the protocols approved by the Animal Care and Use
Committee in Louisiana State University Health Science Center at
New Orleans, and conformed with National Institutes of Health
guidelines.
Fear-conditioning training
The procedures for training in FCT were the same as described
previously [33]. Briefly, the conditioned stimulus (CS) was a tone
at 90 dB and 2,800 Hz, and the unconditioned stimulus (US) was
foot shock at 0.8 mA. During training, adult mice [2–3 months
old; either B6/CBA F1 mice (from the Jackson Laboratory) or hip-
eEF-2K-tg mice and their wild-type littermates] were individually
put into the shock chamber and were allowed to freely explore the
environment for 150 sec in the chamber. Afterward, the CS was
delivered for 30 sec, and at the last 2 sec of the CS, the US was
delivered. After the CS/US pairing, mice were allowed to staying
in the chamber for another 30 sec and then were returned to their
homecages.
cDNA microarray
The procedures for cDNA microarrays were the same as
described previously [64]. Briefly, three groups of adult (2–
3 months old) B6/CBA F1 mice, together with a group of naı ¨ve
control mice (the same strain; without shock, but with exposure to
the shock chamber), were sacrificed at 30, 60, and 120 min after
the training in the FCT, respectively. The total RNA was
extracted from the hippocampi and amygdalae with Trizol
(Invitrogen) and was purified with RNEasy columns (Qiagen).
Reverse transcription (RT) was performed using the SuperScriptH
III First-Strand synthesis system (Invitrogen). All samples were
hybridized in duplicate to Affymetrix 420 2.0 Array Chips, which
was conducted by the Core Facility at the University of Chicago.
The same cDNA microarray was repeated in three individual
mice. The array expression values were generated using
Affymetrix Microarray Suite 5.0 and dChip analyzer 1.3.
Quantitative analysis of dephospho-eEF-2
Protein lysates were prepared from the hippocampi, amygdalae,
and cortices of three groups of mice that were respectively
sacrificed at 30 min, 2 hr, and 4 hr after the training in FCT. To
exclude any non-specific effects, four control conditions were
designed: naı ¨ve control (NC; mice were sacrificed without any
treatment), shock control (SC; mice were sacrificed immediately
after receiving the US), contextual control (CC; mice were
sacrificed 30 min, 2 hr, or 4 hr after being exposed to the shock
chamber for 5 min but without shock), and tone control (TC; mice
were sacrificed 30 min, 2 hr, or 4 hr after being exposed to the
CS). A total of 100 mg of protein lysates from each sample was
separated by an SDS-PAGE (8%) and then was transferred onto
Immobilon-P membranes (Millipore). The membranes were
incubated with either anti-phospho-eEF-2 antibody (1:2,000) or
anti-total eEF-2 antibody (1:2,000; all from Cell Signaling and
Technology Laboratories), followed by HRP-conjugated second-
ary antibody (1:4,000; Jackson ImmunoReseach). Blotting signal
was visualized with the ECL detection system (Pierce). The same
membranes were re-probed to anti-b-actin antibody (1:10000,
Santa Cruz Biotechnology Inc). Densitometry was performed
using Image J Analysis software (version 1.39c). The phosphory-
lation ratio (%) was calculated as: (total eEF-2 - phospho-eEF-2)/
total eEF-2 X 100. In order to minimize the artificial signal, the
exposure time was the same for the membranes used to detect the
total eEF-2 and phospho-eEF-2. The dephospho-eEF-2 ratio (%)
after the training was calculated as: [phospho-eEF-2 of naive
hippocampus (or amygdala) - phospho-eEF-2 of trained hippo-
campus (or amygdala)/phospho-eEF-2 of naive (or amygdala) X
100%]. The change in the total eEF-2 ratio was calculated as:
[total eEF-2 of wild-type hippocampus (or amygdala) - total eEF-2
of transgenic hippocampus (or amygdala)/total eEF-2 of wild-type
hippocampus (or amygdala) X 100%]. The expression level in
each sample was normalized to the expression level of b-actin
before the calculation. The quantitative data were the average of
the levels from 5–6 mice, with at least 2 measures in each animal.
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An NMDA receptor antagonist, MK-801 (St. Louis, MO;
0.2 mg/kg), was administered (i.p.) immediately after the training
in FCT. Both contextual and cued conditionings were examined at
2 hr or 24 hr after the MK-801 treatment with two separate sets of
mice. The procedures for memory retention test are described
below. Another three groups of mice (naı ¨ve/vehicle, training/
MK-801, and training/vehicle) were used for immunoblotting
experiments, in order to determine the phospho-eEF-2 level as
described above.
Generation of hip-eEF-2K-tg mice
An advanced transgenic approach was used in this study. Two
independent transgenic mouse strains were needed. One was Cre
transgenic mouse strain, in which the expression of the Cre
recombinase was under the control of h-CaMK-II promoter. An
8.5 kb of h-CaMK-II promoter was used to drive a 2.6 kb of Not I
transgene cassette that consisted of a 0.6 kb exon-intron splicing
signal, a 0.4 kb element encoding a nuclear localization signal
(pBS317), a 1.029 kb Cre cDNA, and a 0.6 kb poly-A signals
(pNN265). All these components were subcloned into a pBS(2)
vector. Due to some locus effects, the random insertion of h-
CaMK-II promoter into the mouse genome could generate
different expression patterns of the transgene. In our Cre
transgenic mice, the expression of Cre was exclusively observed
in most parts of the hippocampus. The other mouse strain was
eEF-2K transgenic mice, in which the expression of the eEF-2K
transgene was under the control of a chicken b-actin promoter so
that the transgene would express in all types of cells. However, a
transcriptional silencer (stop sequence) was put upstream of the
eEF-2K cDNA to silence its transcription. Moreover, this stop
sequence was flanked by two loxP elements. A recombination by
the Cre recombinase led to the deletion of the stop sequence so
that the expression of the eEF-2K transgene occurred in the brain
regions where Cre expressed. The eEF-2K cDNA was cloned from
the total RNA extracted from a brain of a B6/CBA F1 mouse with
the primers of 59-GCA ACA TGG CAG ACG AAG ACC TCA
TC-39 and 59 GGG GCA GTT ATT CCT CCA TCT GGG CC-
39. The cDNA was confirmed by sequencing. The eEF-2K cDNA
was flanked by an artificial intron and SV-40 poly-A signal, all
from pNN265, in order to ensure a correct translation and to
make the transgene distinguishable from the endogenous eEF-2K
gene. Embryo donors and foster mothers were all from B6/CBA
F1 mice (Jackson Laboratory), in order to (1) have a similar
genomic background between transgenic mice and their wild-type
littermates, (2) have a better genetic background for behavioral
analysis, and (3) have a comparable genetic background to the
non-transgenic studies as shown in Figure 2. After being linearized
with appropriate restriction enzymes, the expression cassette was
injected into the pro-nuclei of B6/CBA F1 zygotes to produce
transgenic founders. The transgene copy number in the founders
was determined by Southern blots (data not shown). In order to
have a higher expression level of the eEF-2K transgene, a founder
with a gene copy number of about 12 of the eEF-2K transgene was
bred into Cre transgenic mice to produce double transgenic mice.
The genotypes of mice were determined by PCR analyses of the
genomic DNA from the tails, which respectively detected the Cre
transgene and the eEF-2K transgene.
in situ hybridization. The procedures for in situ hybridization
were the same as described previously [33]. Briefly, an oligo probe
(59- CAC CAC AGA AGT AAG GTT CCT TCA CAA AGA
TCC TCT AGC-39) that specifically recognized the eEF-2K
transgene only was 35S-labeled. Coronal brain sections (20 mm)
were made with a Cryostat (Leica, CM 1900), and the
hybridization was the same as described in our previous
publication [33]. After being washed, the brain sections were
exposed to Kodak Hyperfilm
TM MP film. The hybridization signal
was visualized with an Olympus B X 51 TF microscope and
analyzed with the Q-imaging system.
Histology
The procedures for histological experiments were the same as
described previously [65]. Briefly, mice were anesthetized with
sodium pentobarbital (Sigma-Aldrich) and were perfused transcar-
dially with 0.9% saline followed by 4% paraformaldehyde (PFA).
Brains were removed and post-fixed overnight with 4% PFA in
30% sucrose. Coronal brain sections (40 mm) were made with the
Cryostat and were then used for Nissl (cresyl violet) staining. For
Golgi-impregnated staining, mice were anesthetized and perfused
transcardially with 0.9% saline followed by 4% PFA. Brains were
kept in Golgi-Cox solution with light-tighten for 6 days and then in
30% sucrose for another 2–3 days. Brains were mounted on
sectioning stages with cyanocacrylic glue. A vibratome (Leica,
VT1200) was used to make brain sections (200 mm), which were
then mounted onto 2% gelatinized microscope slides. Once
mounted, the blotted slides were kept in a humidity chamber until
ready to be stained. For staining, the slides were placed in glass
staining tray and processed as following: (1) Rinsed in distilled
water for 1 min; (2) Placed in ammonium hydroxide for 30 min in
the dark; (3) Rinsed in distilled water for 1 min; (4) Placed in
Kodak Fix for film for 30 min in the dark; (5) Rinsed in distilled
water for 1 min; and (6) Dehydration with 50% to 100% EtOH
for a couple of times at each steps, and then were mounted with a
cover-lip.
Protein synthesis under the normal conditions
L-[35S]-methionine incorporation rate was examined, in order
to evaluate protein synthesis. Both hip-eEF-2K-tg and wild-type
littermate mice were treated (i.p.) with a single dose of L-[35S]-
methionine (150 mCi/animal, specific activity 151 Ci/mmol, GE
Healthcare), and were sacrificed 2 hr after the treatment by
decapitation. For quantitative analysis, brain tissues including the
hippocampus and cortex (control) were quickly dissected from
brains and protein lysates were prepared for liquid scintillation
analysis as described elsewhere [29]. The concentration of L-
[35S]- methionine incorporation into proteins in these tissues was
calculated based on tissue weight. To map the brain region-
specific protein synthesis, serial coronal brain sections (20 mm)
were made on the Cryostat and autoradiography of L-[35S]-
methionine incorporation (exposed to Kodak Hyperfilm
TM MP
film, Amersham for 10 days) was conducted as described
elsewhere [66]. The -[35S]- methionine incorporation signal was
analyzed with an Olympus microscope (SZ-PT) and the Q-
imaging system.
Protein synthesis under the conditions of enhanced
neuronal activity
To evoke neuronal activity in the hippocampus, both hip-eEF-
2K-tg and wild-type mice were treated (i.p.) with a single dose of
KA (Sigma; 20 mg/kg), a non-NMDA receptor agonist, and were
divided into 5 sub-groups. Behavioral responses were observed in
their homecages and these five groups of mice were then sacrificed
at a time-course of 5, 30, 60 120, and 180 min after the KA-
treatment. The total RNA and protein lysates were extracted from
the whole hippocampi of mice. Real-time RT-PCR (Applied
Biosystem, 7900th) was used to determine the mRNA expression
level for Arc and c-fos. Two customized fluorescence-labeled
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After RT, each reaction contained 5 ml Taqman Universal PCR
Mastermix in a total volume of 10 ml containing 1.25 mlR T
production. PCR reactions were conducted under the condition of
95uC for 10 min followed by 40 cycles of 30 sec at 95uC and
1 min at 60uC. The expression levels for both Arc and c-fos were
normalized with 18S rRNA level. Final quantitative analysis was
based on two measures (duplicate samples) in each mouse with a
total of at least 4 mice in each group. Western blots were used to
determine the expression of Arc and c-Fos at the protein level as
described above. The concentrations of the anti-Arc antibody and
anti-c-Fos antibody were both at 1:2000 and these antibodies were
purchased from Cell Signaling Technology Inc. The amount of
protein loading was normalized by b-actin immunoblotting.
Quantitative analysis was based on two measures in each mouse
and in each group at least 5 mice were examined. The comparison
of the ratio between the mRNA expression and protein expression
within the same animal as well as the comparison of the difference
in this ratio between wild-type and hip-eEF-2K-tg mice would
provide a valuable means to test the specific inhibition at the
translational level.
Short-term and long-term memory
Both FCT and water maze test were used to examine memory
functions [33]. For the FCT, both wild-type and hip-eEF-2K-tg
mice (2–3 months old, with both female and male mice mixed)
were trained with a one-trial protocol. For short-term memory, a
retention test was conducted 30 min after the training. Both
contextual and cued conditionings were examined. For contextual
conditioning, mice were individually put back into the chamber
where they received CS/US pairing, and freezing responses were
recorded for 5 min with a sampling method at an interval of 5 sec.
For cued conditioning, mice were individually put into a novel
chamber and 3 min later, the same tone that was used during the
training session was delivered for 3 min. Freezing responses were
recorded in both pre-tone and during-tone periods. Freezing was
defined as no movement of any part of the body, except for
respiration. For long-term memory, every test was the same as
described above, except for that the intervals between the training
and retention test were 1 day and 10 days, respectively, with the
use of two separate sets of animals. For the Morris water-maze test,
a water tank with 1 meter in diameter and a computerized video-
tracking system were used. A training protocol of 5 training
sessions was used. Each training session per day contained 4 trials,
with each trial lasting for 60 sec. The order of the quadrants for
each mouse being released into the water tank was randomly
designed for each session. The interval between each two trials was
about 1 hr. After each trial, mice were towel dried and were
immediately returned to their homecages. Escape latency to the
platform, swimming speed, and swimming path were automati-
cally recorded and the data were analyzed by a Nodel navigation
tracking system (EthoVision, Pro-Noldus). One probe test was
conducted 24 hr after the completion of all training sessions.
During the probe test, the platform was removed, and mice were
individually allowed to swimming in the pool for 60 sec. Time
spent in each quadrant and times crossing over the place that the
platform was previously located during the training sessions were
recorded to determine long-term spatial memory.
Open-field behaviors in hip-eEF-2K-tg mice
Open-field behaviors were examined by using an automatic-
recording open-field working station (MED Associates, Georgia,
VT) as described in our previous publication [67]. Briefly, the
open-field box was illuminated by a dim light (20 lux) and two sets
of 16 pulse-modulated infrared photobeams were placed on
opposite walls 2.5 cm apart to record X-Y ambulatory move-
ments. Mouse behaviors in the box were computer-interfaced at a
sampling rate of 100-ms resolution. Before testing, mice were
transported into the behavioral room to adapt to the environment
for at least 1 hr. Behavioral responses of mice in the box were
recorded for 60 min. The total path length and rearing times were
recorded automatically.
Electrophysiology
The procedures for electrophysiological recording were de-
scribed in our previous publication [68]. Briefly, transverse
hippocampal slices (400 mm) were cut from brains of wild-type
and hip-eEF-2K-tg mice (2–3 months old), kept submerged at
27uC–28uC, and superfused (1–2 ml/min) with oxygenated (95%
O2, 5% CO2) artificial cerebrospinal fluid (ACSF). Bipolar
tungsten stimulating electrodes were placed in the CA1&3 to
stimulate the Schaffer collateral and commissural fibers, and
extracellular field EPSPs (fEPSPs) were recorded with a glass
microelectrode (2–3 MU, filled with 2 M NaCl) positioned in the
hippocampus. Baseline stimulation frequency was 2 min-1, and
the intensity of the 0.1 ms pulses was adjusted to evoke 35%–40%
maximal fEPSPs. Tetanic LTP was induced by high-frequency
stimulation in brief trains (100 Hz, 1 s) applied either as a single
train or four trains separated by 5 min intervals. To reduce day-to-
day variability, simultaneous recordings were obtained from two
slices. Data were recorded from wild-type and hip-eEF-2K-tg
slices. The experimenters were blind to the mouse genotype.
Statistical Analyses
Dada was analyzed by Student’s t test or one-way ANOVA
followed by the Bonferroni post hoc test wherever it was
appropriate. A p value that was less than 0.05 was considered
significance.
Supporting Information
Figure S1 Constructs for transgenic mice. A. Expression vector
for the Cre transgenic mice, which consists of an 8.5 kb of a-
CaMKII promoter and a 2.6 kb Not I fragment encoding Cre
gene. B. Expression vector for eEF-2K transgenic mice, which
consists of a chicken b-actin promoter (3.1 kb), a stop signal that is
flanked by two loxP elements (1.5 kb) and an eEF-2K cDNA that
is flanked by an artificial intron and SV-40 poly-A signal.
Found at: doi:10.1371/journal.pone.0007424.s001 (1.44 MB TIF)
Figure S2 Open-field behaviors in hip-eEF-2K-tg mice. A.
Total movement time. B. Total travel time. C. Rearing numbers.
No significant difference was found in any of these indexes
between wild-type (wt, n=11) and hip-eEF-2K-tg (tg, n=12)
mice. Cent: center area; Peri: peripheral area.
Found at: doi:10.1371/journal.pone.0007424.s002 (1.74 MB TIF)
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